Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.

Lalatsa, A

Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration. [electronic resource] - Journal of controlled release : official journal of the Controlled Release Society Jan 2015 - 87-96 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-4995

10.1016/j.jconrel.2014.10.028 doi


Administration, Intravenous
Analgesics--administration & dosage
Animals
Animals, Outbred Strains
Brain--metabolism
Chitosan--administration & dosage
Enkephalin, Leucine--administration & dosage
Liver--metabolism
Male
Mice, Inbred BALB C
Nanofibers--administration & dosage
Pain--drug therapy
Prodrugs--administration & dosage
Rats, Sprague-Dawley